Maintenance or Consolidation Therapy in Advanced Ovarian Cancer-Reference-Cited by-同舟云学术

Maintenance or Consolidation Therapy in Advanced Ovarian Cancer

Published:2006 Issue:5 Volume:70 Page:315-324
ISSN:0030-2414
Container-title:Oncology
language:en
Short-container-title:Oncology

Author:

Pectasides D.,Pectasides E.

Publisher

S. Karger AG

Subject

Cancer Research,Oncology,General Medicine

Reference43 articles.

1. Cyclophosphamide and Cisplatin Compared with Paclitaxel and Cisplatin in Patients with Stage III and Stage IV Ovarian Cancer

2. Randomized Intergroup Trial of Cisplatin-Paclitaxel Versus Cisplatin-Cyclophosphamide in Women With Advanced Epithelial Ovarian Cancer: Three-Year Results

3. Phase III Randomized Study of Cisplatin Versus Paclitaxel Versus Cisplatin and Paclitaxel in Patients With Suboptimal Stage III or IV Ovarian Cancer: A Gynecologic Oncology Group Study

4. Maybe More Is Better

5. Thigpen T: Current controversies in ovarian cancer: maintenance chemotherapy as standard care. 2004 Educational Book. New Orleans, 40th Annual Meeting of the American Society of Clinical Oncology, pp 281-284.

Cited by 16 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Surgery-based radiation-free multimodality treatment for locally advanced cervical cancer;Taiwanese Journal of Obstetrics and Gynecology;2024-09

2. Response to Multi-Line Chemotherapy in Non-Serous Epithelial Ovarian Cancer;Journal of Obstetrics and Gynaecology Canada;2020-10

3. The iron chelator desferrioxamine synergizes with chemotherapy for cancer treatment;Journal of Trace Elements in Medicine and Biology;2019-12

4. Neoadjuvant chemotherapy and chemotherapy cycle number: A national multicentre study;Gynecologic Oncology;2017-11

5. MicroRNA-200c and microRNA-141 as potential diagnostic and prognostic biomarkers for ovarian cancer;Tumor Biology;2015-02-01